University of Antananarivo

About: University of Antananarivo is a education organization based out in Antananarivo, Madagascar. It is known for research contribution in the topics: Population & Lemur. The organization has 1561 authors who have published 1703 publications receiving 30922 citations. The organization is also known as: Tananarive University & Antananarivo University.

A new genus of polystomatid parasitic flatworm (Monogenea: Polystomatidae) without free-swimming life stage from the Malagasy poison frogs.

Abstract: Madapolystoma n. g. (Monogenea, Polystomatidae), is proposed for a new genus of polystomatid from the urinary bladder of the Malagasy poison frogs of the genus Mantella (family Mantellidae), with the description of one new species. This is the second anuran polystome to be described from Madagascar. The parasites are small with a maximum body length of less than 3 mm. The two gut caeca have a few diverticulae but no prehaptoral anastomoses and are confluent posteriorly. The haptor bears six well-developed suckers and one pair of hamuli. A single small ovary lies in mid-body while the single follicular testis lies posteriorly in the body. Vaginae are present. The new genus is unique among all known polystomes in that it apparently has no free-swimming ciliated larvae but instead is characterized by advanced intra-uterine development with larvae developing hamuli and even suckers while still in utero . Based on molecular phylogenetic data, the closest relative of Madapolystoma is the genus Eupolystoma from Africa. Madagascar has a very diverse anuran fauna with a 100% level of endemicity at the species level, and more Madapolystoma species from other mantellid hosts await description.

High mortality and annual fecundity in a free‐ranging basal placental mammal, Setifer setosus (Tenrecidae: Afrosoricida)

Abstract: The spiny tenrecs, an endemic subfamily of Malagasy insectivores (Tenrecinae), are wide ranging and fairly conspicuous, yet long-term studies on free-ranging populations remain sparse. Basal to most eutherian mammals, they share many ecological and morphological traits with proposed eutherian ancestors. Understanding of their unusual life histories is therefore important to the understanding of mammalian evolution. Here we present the results of a 3-year study on a population of Setifer setosus in the dry deciduous forest of Western Madagascar. The annual activity cycle of this species includes a 5–7-month hibernation period, during the dry season, and a dramatic increase in body mass during the active season. Females, observed giving birth to up to three litters in a single season, entered hibernation later than males, after weaning their last litter. Short intervals between parturition dates and simultaneous gestation and lactation provide evidence of post-partum oestrus, previously observed in only one other species of tenrec (Geogale aurita, subfamily:Geogalinae). High levels of mortality, primarily by snakes and ground predators, were also observed and likely contribute, along with the unpredictability of Madagascar’s climate, to the unusually fast life history of these mammals.

Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: results from a nationwide systematic random sampling.

Abstract: Retention on lifelong antiretroviral therapy (ART) is essential in sustaining treatment success while preventing HIV drug resistance (HIVDR), especially in resource-limited settings (RLS). In an era of rising numbers of patients on ART, mastering patients in care is becoming more strategic for programmatic interventions. Due to lapses and uncertainty with the current WHO sampling approach in Cameroon, we thus aimed to ascertain the national performance of, and determinants in, retention on ART at 12 months. Using a systematic random sampling, a survey was conducted in the ten regions (56 sites) of Cameroon, within the “reporting period” of October 2013–November 2014, enrolling 5005 eligible adults and children. Performance in retention on ART at 12 months was interpreted following the definition of HIVDR early warning indicator: excellent (>85%), fair (85–75%), poor (<75); and factors with p-value < 0.01 were considered statistically significant. Majority (74.4%) of patients were in urban settings, and 50.9% were managed in reference treatment centres. Nationwide, retention on ART at 12 months was 60.4% (2023/3349); only six sites and one region achieved acceptable performances. Retention performance varied in reference treatment centres (54.2%) vs. management units (66.8%), p < 0.0001; male (57.1%) vs. women (62.0%), p = 0.007; and with WHO clinical stage I (63.3%) vs. other stages (55.6%), p = 0.007; but neither for age (adults [60.3%] vs. children [58.8%], p = 0.730) nor for immune status (CD4351–500 [65.9%] vs. other CD4-staging [59.86%], p = 0.077). Poor retention in care, within 12 months of ART initiation, urges active search for lost-to-follow-up targeting preferentially male and symptomatic patients, especially within reference ART clinics. Such sampling strategy could be further strengthened for informed ART monitoring and HIVDR prevention perspectives.

Efficacy of artesunate-amodiaquine in the treatment of falciparum uncomplicated malaria in Madagascar.

Abstract: Since 2006, the artemisinin-based combination therapy (ACT) are recommended to treat uncomplicated malaria including non Plasmodium falciparum malaria in Madagascar. Artesunate–amodiaquine (ASAQ) and artemether–lumefantrine are the first- and second-line treatment in uncomplicated falciparum malaria, respectively. No clinical drug efficacy study has been published since 2009 to assess the efficacy of these two artemisinin-based combinations in Madagascar, although the incidence of malaria cases has increased from 2010 to 2016. In this context, new data about the efficacy of the drug combinations currently used to treat malaria are needed. Therapeutic efficacy studies evaluating the efficacy of ASAQ were conducted in 2012, 2013 and 2016 among falciparum malaria-infected patients aged between 6 months and 56 years, in health centres in 6 sites representing different epidemiological patterns. The 2009 World Health Organization protocol for monitoring anti-malarial drug efficacy was followed. A total of 348 enrolled patients met the inclusion criteria including 108 patients in 2012 (n = 64 for Matanga, n = 44 for Ampasipotsy), 123 patients in 2013 (n = 63 for Ankazomborona, n = 60 for Anjoma Ramartina) and 117 patients in 2016 (n = 67 for Tsaratanana, n = 50 for Antanimbary). The overall cumulative PCR-corrected day 28 cure rate was 99.70% (95% IC 98.30–99.95). No significant difference in cure rates was observed overtime: 99.02% (95% IC 94.65–99.83) in 2012; 100% (95% IC 96.8–100) in 2013 and 100% (95% IC 96.65–100) in 2016. The ASAQ combination remains highly effective for the treatment of uncomplicated falciparum malaria in Madagascar.